publication venue for
- Correction to: PRESTO 2: An International Survey to Evaluate Patients’ Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly 2024
- Exploring Perceptions of Biologic Therapies: A Qualitative Study Among Canadians Living with Severe Asthma 2024
- Health Economic Assessments of Hyaluronic Acid Treatments for Knee Osteoarthritis: A Systematic Review. 41:65-81. 2024
- Effect of Nintedanib in Patients with Progressive Pulmonary Fibrosis in Subgroups with Differing Baseline Characteristics. 40:5536-5546. 2023
- Correction to: DElaying Disease Progression In COPD with Early Initiation of Dual Bronchodilator or Triple Inhaled PharmacoTherapy (DEPICT): A Predictive Modelling Approach. 40:4689-4690. 2023
- DElaying Disease Progression In COPD with Early Initiation of Dual Bronchodilator or Triple Inhaled PharmacoTherapy (DEPICT): A Predictive Modelling Approach. 40:4282-4297. 2023
- Real-World Persistence of Ustekinumab in the Treatment of Inflammatory Bowel Disease. 40:4421-4439. 2023
- A Response to: Letter to the Editor Regarding “Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-analysis”. 40:2556-2561. 2023
- PRESTO 2: An International Survey to Evaluate Patients’ Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly. 40:671-690. 2023
- Comparative Efficacy of Umeclidinium/Vilanterol Versus Other Bronchodilators for the Treatment of Chronic Obstructive Pulmonary Disease: A Network Meta-Analysis. 39:4961-5010. 2022
- Correction to: Comparative Efficacy of Umeclidinium/Vilanterol Versus Other Bronchodilators for the Treatment of Chronic Obstructive Pulmonary Disease: A Network Meta-Analysis. 39:5011-5012. 2022
- Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis. 39:3957-3978. 2022
- The Antifibrotic Effects of Inhaled Treprostinil: An Emerging Option for ILD. 39:3881-3895. 2022
- Clinical Radiofrequency Ablation Outcomes of Combined Sensory Nerve Branch and Dorsal Entry Root Zone Complex Lesions for Sacroiliac Joint Complex Pain. 39:3539-3546. 2022
- Economic Evaluation of Budesonide Orodispersible Tablets for the Treatment of Eosinophilic Esophagitis: A Cost–Utility Analysis. 38:5737-5751. 2021
- Psychometric Evaluation of ITP Life Quality Index (ILQI) in a Global Survey of Patients with Immune Thrombocytopenia. 38:5791-5808. 2021
- Efficacy of Agomelatine 25–50 mg for the Treatment of Anxious Symptoms and Functional Impairment in Generalized Anxiety Disorder: A Meta-Analysis of Three Placebo-Controlled Studies. 38:1567-1583. 2021
- Global Quality Statements on Reliever Use in Asthma in Adults and Children Older than 5 Years of Age. 38:1382-1396. 2021
- Naltrexone’s Impact on Cancer Progression and Mortality: A Systematic Review of Studies in Humans, Animal Models, and Cell Cultures. 38:904-924. 2021
- The Design and Rationale of the Trail1 Trial: A Randomized Double-Blind Phase 2 Clinical Trial of Pirfenidone in Rheumatoid Arthritis-Associated Interstitial Lung Disease. 36:3279-3287. 2019
- The Impact of Excluding Patients with End-Stage Knee Disease in Intra-Articular Hyaluronic Acid Trials: A Systematic Review and Meta-Analysis. 36:147-161. 2019
- Once-Daily Triple Therapy in Patients with Advanced COPD: Healthcare Resource Utilization Data and Associated Costs from the FULFIL Trial. 34:2163-2172. 2017
- Potential Impact of Biologically Derived Hyaluronic Acid on Quality of Life in Patients with Knee Osteoarthritis in the United States. 33:2200-2210. 2016
- Response to: Important Considerations When Determining the Cost-effectiveness of Viscosupplements in the Treatment of Knee Osteoarthritis. 33:2273-2276. 2016
- Cost-Effectiveness of Different Forms of Intra-Articular Injections for the Treatment of Osteoarthritis of the Knee. 33:998-1011. 2016
- A Follow-up Study to Monitor Adult Height Among Spanish Children with Growth Hormone Deficiency Who Received Biosimilar Human Recombinant Growth Hormone (Omnitrope®) During a Phase III Clinical Trial. 32:148-156. 2015
- Obesity and Mental Illness: Implications for Cognitive Functioning. 30:577-588. 2013
- Jet lag, circadian rhythm sleep disturbances, and depression: the role of melatonin and its analogs. 27:796-813. 2010
- Erratum to: New pharmacotherapy for stroke prevention in atrial fibrillation. 27:493-493. 2010
- New pharmacotherapy for stroke prevention in atrial fibrillation: Update 2010. 26:1058-1071. 2009
- Ramelteon: a review of its therapeutic potential in sleep disorders. 26:613-626. 2009
- The dilution of benzalkonium chloride (BAK) in the tear Film. 23:835-841. 2006
- Twice-daily and once-daily nedocromil sodium 2% ophthalmic solution for the treatment of seasonal allergic conjunctivitis. 19:9-16. 2002
- Nedocromil sodium in golfers with seasonal allergic conjunctivitis. 18:195-204. 2001
- Efficacy and acceptability of nedocromil sodium 2% and olopatadine hydrochloride 0.1% in perennial allergic conjunctivitis. 17:140-147. 2000